These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1793067)

  • 21. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs.
    Sakuma Y; Tsunoda H; Shirato M; Katayama S; Yamatsu I; Katayama K
    Prostaglandins; 1991 Nov; 42(5):463-72. PubMed ID: 1763202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.
    Yukawa T; Kroegel C; Evans P; Fukuda T; Chung KF; Barnes PJ
    Immunology; 1989 Sep; 68(1):140-3. PubMed ID: 2807369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of apafant on PAF-induced downregulation of beta-adrenoceptors in guinea pigs.
    Sugimoto Y; Nakayama Y; Kishida H; Hayakawa T; Fujiwara R; Kamei C
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):547-52. PubMed ID: 9442478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
    Lu Z; Wolf MB
    Circ Shock; 1993 Sep; 41(1):8-18. PubMed ID: 8403248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-activating factor antagonists in experimental shock.
    Muacevic G; Heuer HO
    Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways.
    Johnson PR; Armour CL; Black JL
    Eur Respir J; 1990 Jan; 3(1):55-60. PubMed ID: 2311732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A possible role for PAF in allergen-induced late responses: modification by a selective antagonist.
    Abraham WM; Stevenson JS; Garrido R
    J Appl Physiol (1985); 1989 May; 66(5):2351-7. PubMed ID: 2745300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of PAF antagonists in experimental models. Therapeutical perspectives].
    Desquand S
    Therapie; 1993; 48(6):585-97. PubMed ID: 8091344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
    Kay AB
    Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for platelet activating factor and platelets in the induction of bronchial hyperreactivity.
    Page CP
    Int J Tissue React; 1987; 9(1):27-32. PubMed ID: 3298115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
    Nabe T; Yamamura H; Kohno S
    Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit.
    Lohman I; Halonen M
    Am Rev Respir Dis; 1990 Aug; 142(2):390-7. PubMed ID: 2382903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412.
    Havill AM; Van Valen RG; Handley DA
    Br J Pharmacol; 1990 Feb; 99(2):396-400. PubMed ID: 2328403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
    Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
    Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
    J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170).
    Heuer HO
    Eur J Pharmacol; 1991 Jun; 199(2):157-63. PubMed ID: 1954975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of platelet activating factor and its antagonists in bronchial asthma].
    Massion PB; Frans A
    Rev Pneumol Clin; 1992; 48(2):49-57. PubMed ID: 1384101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.